Nephrology

The Biology of Magnesium Wasting: The KCNA1 Connection

At a Glance

Glaudemans-type hypomagnesemia is an inherited condition associated with some KCNA1 variants that may lead the kidneys to lose magnesium. Low blood magnesium and a high fractional excretion of magnesium support renal wasting, but medicines, kidney function, and hydration affect test results.

Understanding the biology of Isolated Autosomal Dominant Hypomagnesemia (Glaudemans Type) requires looking at how your kidneys act as a high-tech filter. Normally, your kidneys are very efficient at recycling magnesium back into your blood, but a mutation in the KCNA1 gene disrupts this recycling process ^[1]^[2].

The “Electrical Drive” Mechanism

Most of the magnesium your kidneys filter (about 60–70%) is actually reabsorbed early on in a section called the thick ascending limb. However, the final crucial regulation happens further down in the Distal Convoluted Tubule (DCT) ^[3]. To pull that final, highly regulated 5-10% of magnesium out of the urine and back into the body, the kidney cells use a specialized “gate” called TRPM6 ^[3].

This gate works like an electric vacuum—it needs a specific electrical charge (a “gradient”) to pull the magnesium through. The KCNA1 gene provides instructions for a potassium channel called Kv1.1 ^[1]. In the traditional “Glaudemans model,” this potassium channel is thought to maintain that electrical charge. When the KCNA1 gene has a mutation, it alters Kv1.1 function ^[2]. Without the correct electrical drive, the TRPM6 gate cannot properly reabsorb the remaining magnesium, causing it to be lost in the urine ^[1]^[2].

Note: The exact kidney mechanism is still being studied and may be variant-specific, but the link between certain KCNA1 mutations and renal magnesium wasting is clinically recognized ^[1]^[3].

Diagnostic Criteria: The “Wasting” Test

To diagnose this condition, doctors don’t just look at how much magnesium is in your blood; they look at how much your kidney is inappropriately “wasting.”

Serum Hypomagnesemia: A low level of magnesium in the blood (typically below 0.70 mmol/L, though laboratory ranges vary) ^[4]^[5].
Fractional Excretion of Magnesium (FEMg): This is a calculation that compares how much magnesium is in your urine versus your blood. It uses the formula: (Urine Mg × Serum Creatinine) / (Serum Mg × Urine Creatinine) × 100.
- In a person with low blood magnesium, the kidneys should be holding onto every drop. As an approximate interpretive guide, an FEMg greater than 2% while blood levels are low suggests the kidneys are inappropriately wasting magnesium ^[6]^[7].
- In some cases where blood magnesium is near normal, an FEMg higher than 4% may raise suspicion for wasting ^[6].
- Importantly, these percentages are not rigid diagnostic rules. Your clinician must interpret them alongside your kidney function (eGFR), current medications, supplements, and hydration status ^[6]^[8].

Differentiating From Other Disorders

Because many genetic conditions cause low magnesium, doctors use specific clues to tell them apart:

Condition	Key Differences from KCNA1 (Glaudemans)
TRPM6 Disorders	Usually causes much more severe magnesium loss and low calcium; often inherited from both parents (recessive) ^[9]^[10].
CLDN16 / CLDN19	Causes high levels of calcium in the urine, kidney stones, and “calcium deposits” (nephrocalcinosis) ^[11]^[12].
CNNM2 Mutations	Can look very similar but often includes neurological symptoms like cognitive delays ^[13]^[14].
Gitelman Syndrome	Includes low potassium and high blood pH (alkalosis), which are not typical for Glaudemans type ^[15].

Laboratory Completeness Checklist

If you are reviewing your own lab reports, ensure they contain the following “gold standard” information for a rare renal diagnosis:

Paired Measurements: Serum magnesium and urine magnesium taken at the same time ^[6].
Creatinine Baseline: Your serum creatinine and eGFR (kidney function), as low kidney function can make FEMg results harder to interpret ^[6]^[8].
Genetic Variant Details: The specific mutation name (e.g., p.Asn255Asp or p.Leu328Val) and its official classification (e.g., “Pathogenic” or “Likely Pathogenic”) ^[13].
Exclusion of “Acquired” Causes: Documentation that you weren’t taking diuretics or proton-pump inhibitors (PPIs) which could mimic the condition ^[16]^[15].

Common questions in this guide

What is Glaudemans-type hypomagnesemia?

It is a rare inherited kidney disorder associated with certain KCNA1 gene variants. The kidneys lose too much magnesium in the urine, which can lower blood magnesium; the exact mechanism may differ between variants.

What does a fractional excretion of magnesium, or FEMg, test show?

FEMg estimates how much filtered magnesium the kidneys are releasing into urine instead of conserving. When blood magnesium is low, a value above about 2% can suggest kidney wasting, while a value above about 4% may raise concern when blood magnesium is near normal. These are approximate guides affected by kidney function, medicines, supplements, hydration, and sample timing.

How might a KCNA1 variant cause magnesium loss?

KCNA1 provides instructions for Kv1.1, a potassium channel in kidney cells. The traditional model proposes that Kv1.1 helps create the electrical force needed for TRPM6 to reabsorb magnesium in the distal convoluted tubule, but the exact mechanism may vary by variant and is still being studied.

Which tests help distinguish Glaudemans type from other causes of low magnesium?

Evaluation may include paired blood and urine magnesium, serum creatinine and eGFR, urine calcium, and genetic testing. The pattern of urine calcium, potassium, blood acidity, neurological findings, and the specific gene variant can help distinguish this condition from disorders such as TRPM6-related disease, CLDN16 or CLDN19 disorders, CNNM2-related disease, and Gitelman syndrome.

Can medicines or supplements change magnesium and FEMg results?

Yes. Diuretics and proton-pump inhibitors can contribute to low magnesium or affect interpretation, while magnesium supplements can change measured levels. Do not stop a prescribed medicine or supplement without medical advice; ask your clinician whether testing should be repeated under appropriate conditions.

What should a KCNA1 genetic test report include?

The report should identify the exact KCNA1 variant and state its classification, such as pathogenic or likely pathogenic. A genetics professional should interpret that result with your laboratory findings, family history, and evaluation for other genetic or acquired causes.

Get notified when new evidence is published on Isolated autosomal dominant hypomagnesemia, Glaudemans type.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Key takeaways

Glaudemans-type hypomagnesemia is an inherited disorder associated with certain KCNA1 variants and excess magnesium loss through the kidneys.
The proposed mechanism involves the Kv1.1 potassium channel and TRPM6 magnesium transporter in the distal convoluted tubule, but the exact pathway may vary by variant and remains under study.
When blood magnesium is low, an FEMg above about 2% may suggest inappropriate kidney wasting, but it is not a rigid diagnostic cutoff.
Reliable interpretation requires paired serum and urine magnesium, creatinine and eGFR, and review of medications, supplements, hydration, and sample timing.
Urine calcium, kidney stones, low potassium, alkalosis, neurological findings, and genetic variant classification can help distinguish Glaudemans type from similar disorders.

References (16)

1
A de novo KCNA1 Mutation in a Patient with Tetany and Hypomagnesemia.
van der Wijst J, Konrad M, Verkaart SAJ, et al.
Nephron 2018; (139(4)):359-366 doi:10.1159/000488954.
PMID: 29791908
2
Neuromuscular tetanic hyperexcitability syndrome associated to a heterozygous Kv1.1 N255D mutation with normal serum magnesium levels.
Bianchi F, Simoncini C, Brugnoni R, et al.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(1)):36-39 doi:10.36185/2532-1900-007.
PMID: 32607479
3
Renal TRPM6 but not Kv1.1 is required for magnesium homeostasis in mice.
Thaitongsuk P, Girardi ACC, Morrow A, et al.
American journal of physiology. Renal physiology 2026; (331(3)):F398-F410 doi:10.1152/ajprenal.00137.2026.
PMID: 42572410
4
Molecular Mechanisms of Renal Magnesium Reabsorption.
Ellison DH, Maeoka Y, McCormick JA
Journal of the American Society of Nephrology : JASN 2021; (32(9)):2125-2136 doi:10.1681/ASN.2021010042.
PMID: 34045316
5
Hypomagnesemia is underestimated in children with HNF1B mutations.
Kołbuc M, Leßmeier L, Salamon-Słowińska D, et al.
Pediatric nephrology (Berlin, Germany) 2020; (35(10)):1877-1886 doi:10.1007/s00467-020-04576-6.
PMID: 32388583
6
Utility of fractional excretion of magnesium in diagnosing renal magnesium wasting in pediatric nephrology practice.
Awazu M, Matsumura K
Clinical biochemistry 2024; (131-132()):110807 doi:10.1016/j.clinbiochem.2024.110807.
PMID: 39059606
7
Clinical and genetic approach to renal hypomagnesemia.
Tseng MH, Konrad M, Ding JJ, Lin SH
Biomedical journal 2022; (45(1)):74-87 doi:10.1016/j.bj.2021.11.002.
PMID: 34767995
8
Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease.
Grigore TV, Zuidscherwoude M, Witasp A, et al.
Frontiers in endocrinology 2022; (13()):1046392 doi:10.3389/fendo.2022.1046392.
PMID: 36699036
9
Familial hypomagnesemia with secondary hypocalcemia: a novel TRPM6 mutation associated with treatment-resistant migraine in a North African family.
Paola PM, Gianni C, Emanuele M, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(10)).
PMID: 42830330
10
Hypomagnesemia due to two novel TRPM6 mutations.
Coulter M, Colvin C, Korf B, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2015; (28(11-12)):1373-8.
PMID: 26226117
11
Identification of a Novel Homozygous Missense Mutation in the CLDN16 Gene to Decipher the Ambiguous Clinical Presentation Associated with Autosomal Dominant Hypocalcaemia and Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis in an Indian Family.
Thapa R, Roy A, Nayek K, Basu A
Calcified tissue international 2024; (114(2)):110-118 doi:10.1007/s00223-023-01142-8.
PMID: 38078932
12
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis treated with living-donor kidney transplantation: case report.
Kaba A, Kaku K, Shingaki K, et al.
CEN case reports 2026; (15(3)).
PMID: 42095997
13
Novel CNNM2 variant causing hypomagnesemia and early-onset calcium pyrophosphate deposition disease: A case report.
Robert C, Perrot L, Zelus A, et al.
Joint bone spine 2026; (93(1)):105982 doi:10.1016/j.jbspin.2025.105982.
PMID: 41022172
14
Diagnostic Dilemma in an Adolescent Girl with an Eating Disorder, Intellectual Disability, and Hypomagnesemia.
Bamhraz AA, Franken GAC, de Baaij JHF, et al.
Nephron 2021; (145(6)):717-720 doi:10.1159/000518173.
PMID: 34515155
15
Hypomagnesemia, Hypocalcemia, and Tubulointerstitial Nephropathy Caused by Claudin-16 Autoantibodies.
Figueres L, Bruneau S, Prot-Bertoye C, et al.
Journal of the American Society of Nephrology : JASN 2022; (33(7)):1402-1410 doi:10.1681/ASN.2022010060.
PMID: 35728884
16
Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial.
Drenthen LCA, de Baaij JHF, Rodwell L, et al.
Diabetologia 2024; (67(1)):52-61 doi:10.1007/s00125-023-06029-9.
PMID: 37922013

This page is for informational purposes only and does not constitute medical advice. A nephrologist or genetics professional should interpret your magnesium tests, FEMg result, and KCNA1 variant in the context of your kidney function, medicines, and overall health.